Expert Interview
A Second Look: Discussing the Topline Data from TEPEZZA (teprotutumab) in phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED)
Ticker(s): HZNPInstitution: Holyoke Medical Center
- Clinical Endocrinologist with 25 years of experience.
- Manages 30 patients with Thyroid Eye Disease.
- Sub-specialties in Adrenal Disease, Diabetes, Gonad Disorders and Lipid Metabolism.
How many patients with CAS-TED do you treat?
Added By: wilson_adminWhat is your impression of the phase 4 data?
Will you use Tepezza in CAS-TED patients?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
